Skip to main content
Springer Nature Link
Log in

Gastrointestinal cancer

ALASCCA: an aspirin a day keeps colorectal cancer away

  • Research Highlight
  • Published:

From Nature Reviews Clinical Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

Original article

  • Martling, A. et al. Low-dose aspirin for PI3K-altered localized colorectal cancer. N. Engl. J. Med. 393, 1051–1064 (2025)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Clinical Oncology http://www.nature.com/nrclinonc

    David Killock

Authors
  1. David Killock
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to David Killock.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Killock, D. ALASCCA: an aspirin a day keeps colorectal cancer away. Nat Rev Clin Oncol (2025). https://doi.org/10.1038/s41571-025-01082-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41571-025-01082-2

  • Springer Nature Limited